We showed that, under conditions of experimental chronic hepatitis, excessive increases in the levels of a Ca-binding protein, S-100b, and a neuronal cell adhesion molecule, NCAM, occur in all parts of the brain of Wistar rats. This is accompanied by suppression of locomotor and orientational/research activity of the animals and increase in their stress sensitivity. Treatment by α ketoglutarate and cytoflavin in chronic hepatitis provides a clear neuroprotective effect.
Similar content being viewed by others
References
D. Häussinger, “Hepatic encephalopathy,” Acta Gastroenterol. Belg., 73, No. 4, 457–464 (2010).
S. Bengmark, “Bio-ecological control of chronic liver disease and encephalopathy,” Met. Brain Dis., 24, No. 1, 223–236 (2009).
M. J. McPhail and S. D. Taylor-Robinson, “The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy,” Met. Brain Dis., 25, No. 1, 65–72 (2010).
A. Lemberg and M. A. Fernández, “Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress,” Ann. Hepatol., 8, No. 2, 95–102 (2009).
Patent 15752 of Ukraine, MPK G 09 B 23/28, A Technique of Modeling Chronic Hepatitis C, V. Yu. Nikolenko, Yu. I. Nikolenko, and O. Yu. Nikolenko; declarant and owner Donetsk State Medical University, No. u2006004614, publ. 17.07.2006/
G. Ushakova, O. Fed’kiv, O. Prykhod’ko, et al., “The effect of long-term lactobacilli (lactic acid bacteria) enteral treatment on the central nervous system of growing rats,” J. Nutr. Biochem., 20, No. 9, 677–684 (2009).
J. Bureš, O. Burešova, D. P. Hewston, Methods And Main Experiments for Studying the Brain and Behavior [Russian translation], Vysshaya Shkola, Moscow (1991).
J. Steiner, B. Bogerts, M. L. Schroeter, et al., “S100B protein in neurodegenerative disorders,” Clin. Chem. Lab. Med., 49, No. 3, 409–424 (2011).
L. H. Brennaman and P. F. Maness, “NCAM in neuropsychiatric and neurodegenerative disorders,” Adv. Exp. Med. Biol., 663, 299–317 (2010).
R. Donato, G. Sorci, F. Riuzzi, et al., “S100B’s double life: intracellular regulator and extracellular signal,” Biochim. Biophys. Acta., 1793, No. 6, 1008–1022 (2009).
G. Ushakova, O. Fomenko, and S. Pierzynowski, “Noninvasive markers of hepatic encephalopathy under chronic hepatitis C and 2-oxoglutarate treatment,” Ann. Univ. Mariae Curie-Skladowska, Sectio DDD Pharm., 23, No. 3, 203–206 (2010).
A. Dityatev, O. Bukalo, and M. Schachner, “Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules,” Neuron Glia Biol., 4, No. 3, 197-209 (2008).
R. Bisaz, L. Conboy, and C. Sandi, “Learning under stress: a role for the neural cell adhesion molecule NCAM,” Neurobiol. Learn. Mem., 91, No. 4, 333–342 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Neirofiziologiya/Neurophysiology, Vol. 43, No. 3, pp. 235–238, May-June, 2011.
Rights and permissions
About this article
Cite this article
Ushakova, G.A., Fomenko, O.Z. & Pierzynowski, S.G. Changes in the Levels of Neurospecific Proteins and in Behavioral Phenomena in Rats with Hepatic Encephalopathy. Neurophysiology 43, 205–208 (2011). https://doi.org/10.1007/s11062-011-9206-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11062-011-9206-4